Company Search:
Advanced Search
Sponsored Links
Brickell Biotech Inc Company Snapshot
Brickell Biotech Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Brickell Biotech Inc with three other companies in this sector in the United States: Mymetics Corporation (2018 sales of $1.14 million ), Windtree Therapeutics Inc ($1.79 million ), and Idera Pharmaceuticals, Inc. ($662,000.00 of which 100% was Novel Therapeutics).

Sales Analysis. Sales fell dramatically in 2018: Brickell Biotech Inc reported sales of $1.62 million for the year ending December of 2018. This represents a sharp decrease of 88.3% versus 2017, when the company's sales were $13.82 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Brickell Biotech Inc
  Stock Performance Chart for Brickell Biotech Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): 4.14
(Figures in U.S. Dollars)
1 Week 2.0%   13 Weeks -8.4%  
4 Weeks -22.2%   52 Weeks -53.8%  
Brickell Biotech Inc Key Data:
  Ticker: BBI Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 1,622,000
(Year Ending Jan 2019).
Employees: 30
  Currency: U.S. Dollars Market Cap: 13,509,146
  Fiscal Yr Ends: December Shares Outstanding: 3,263,000
  Share Type: Common Closely Held Shares: 30,155
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.